Skip to main content

Emily Greengard, MD, is a UNC Lineberger Comprehensive Cancer Center member and physician specializing in pediatric solid tumors, with a focus on neuroblastoma and sarcomas.

MD
Associate Professor, Pediatric Hematology/Oncology
UNC-Chapel Hill
Clinical Research

Area of Interest

My areas of interest are pediatric solid tumors, with a focus on neuroblastoma and sarcomas.

I am a clinical trialist and develop and execute clinical trials, particularly early phase clinical trials, for the treatment of pediatric solid tumors. I am also very active in Children’s Oncology Group Neuroblastoma Committee and currently serve as Vice Chair for a Phase 3 trial; my focus is on the addition of an ALK inhibitor to the treatment of children with ALK aberrant high-risk neuroblastoma.

I am very interested in integrative oncology and will be working to develop a pediatric integrative oncology program, which will have both a clinical and research component.

Find publications on PubMed

Awards and Honors

  • Team Science Award, University of Minnesota Department of Pediatrics, 2020
  • Top Doctor, Minneapolis St. Paul Magazine, 2020-2024
  • Innovators in Translational Research, Department of Pediatrics, University of Minnesota (translating VX15/2503 from bench to bedside), 2018
Headshot of Emily Greengard.